CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èµ¿Çö
  • ÇǺΰúÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °Ç¼±/ÇǺξÏ/»ö¼Ò¼ºÁúȯ/Å»¸ð/µÎÇÇÁúȯ
  • Á÷ À§: ±³¼ö(ÇǺΰúÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
185 (±¹¿Ü)SCI Spatial transcriptomic profiling reveals the pathophysiology of early-stage hidradenitis suppurativa
184 (±¹¿Ü)SCI Cannabidiol mediates epidermal terminal differentiation and redox homeostasis through aryl hydrocarbon receptor (AhR)-dependent signaling.
183 (±¹¿Ü)SCIE Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment
182 (±¹¿Ü)SCI "A case of severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab"
181 (±¹³»)SCIE Innate immunity protein markers are significantly elevated in hidradenitis suppurativa skin than in psoriasis vulgaris
180 (±¹¿Ü)SCI International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
179 (±¹³»)SCIE Possible role of arginase 1 positive microglia on depressive/anxiety-like behaviors in atopic dermatitis mouse model
178 (±¹¿Ü)SCI Profilin-1 prevents psoriasis pathogenesis through I¥êB¥æ regulation
177 (±¹³»)KCI Pembrolizumab¿¡ ÀÇÇØ À¯¹ßµÈ µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ 1¿¹
176 (±¹³»)KCI À¯¹æ¿¡ ¹ß»ýÇÑ ÇÇÁö¼± »óÇÇÁ¾ 1¿¹
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729